Leonard Bell, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 11,129 shares at $138.02 ($1.5M) on 2016-02-08, disclosed to the SEC on 2016-02-08.
Seasonal sale ($1.5M) by Director — this insider has traded ALXN in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $138.02 | 1,037 | $143K | 9.3% |
| 2 | $138.02 | 10,092 | $1.4M | 90.7% |
| Total | $138.02 avg | 11,129 | $1.5M | 100% |
| Filing → |
| ALXN | SELL | 2017-02-08 | $2.2M | — | Filing → |
| ALXN | SELL | 2017-01-13 | $14K | — | Filing → |
| ALXN | SELL | 2017-01-09 | $5.5M | — | Filing → |